Page last updated: 2024-09-03

imatinib mesylate and Carcinoma, Anaplastic

imatinib mesylate has been researched along with Carcinoma, Anaplastic in 30 studies

Research

Studies (30)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	19 (63.33)	29.6817
2010's	10 (33.33)	24.3611
2020's	1 (3.33)	2.80

Authors

Authors	Studies
Awale, L; Deo, KB; Gautam, S; Pandit, N; Pradhan, A; Yadav, TN	1
Beadling, C; Bertagnolli, MM; Corless, CL; Demetri, GD; Fletcher, JA; Heinrich, MC; Lee, JC; Mariño-Enríquez, A; Morgan, JA; Ravegnini, G; Serrano, C; Wang, Y	1
Hayakumo, T; Ikura, Y; Iwai, Y; Kadota, C; Shigaki, Y	1
Dahmoush, L; Guseva, NV; Ma, D; Robinson, RA	1
Friman, T; Gustafsson, R; In 't Zandt, R; Kalamajski, S; Maccarana, M; Oldberg, Å; Olsson, PO; Rubin, K; Tykesson, E	1
Agaimy, A; Bonekamp, D; Brors, B; Dieter, SM; Ehrenberg, KR; Eils, R; Federspil, PA; Fröhlich, M; Fröhling, S; Glimm, H; Gröschel, S; Heining, C; Huebschmann, D; Hutter, B; Jung, CS; Kriegsmann, M; Mavratzas, A; Penzel, R; Reuss, DE; Schirmacher, P; Schlemmer, HP; Schlesner, M; Scholl, C; Stenzinger, A; von Kalle, C; Weichert, W; Wolf, S	1
Bovée, JV; Gelderblom, H; Hogendoorn, PC; Kroep, JR; van der Molen, AJ	1
Damaj, G; Garidi, R; Marolleau, JP; Parcelier, A; Roszkiewicz, F; Royer, B; Vaida, I	1
Giordano, T; Ha, HT; Koenig, RJ; Lee, JS; Sisson, J; Urba, S; Worden, FP	1
Abdelhay, E; Amarante-Mendes, GP; Binato, R; Bueno-Da-Silva, AE; Castro, FA; Colassanti, MD; De Carvalho, DD; Jacysyn, JF; Leroy, JM; Pereira, WO; Proto-Siqueira, R; Zago, MA; Zanichelli, MA	1
Bousquet, G; Faugeron, I; Hindie, E; Lussato, D; Toubert, ME; Vercellino, L	1
O'Bryan, KW; Ratner, D	1
Kim, E; Matsuse, M; Mitsutake, N; Ohtsuru, A; Saenko, V; Suzuki, K; Yamashita, S	1
Bodurka, DC; Broaddus, R; Gershenson, DM; Lu, KH; Malpica, A; Schmandt, RE; Shvartsman, H; Sun, C; Thornton, A	1
McMullan, C; Mitsiades, CS; Mitsiades, N; Poulaki, V; Sykoutri, D	1
Bucana, CD; Evans, DB; Fidler, IJ; Hwang, RF; Killion, JJ; Tsan, R; Yokoi, K	1
Bellone, G; Carbone, A; Davidson, W; De Quadros, MR; Dughera, L; Emanuelli, G; Ferrero, D; Gramigni, C; Mioli, P; Prati, A; Rodeck, U	1
Hoffer, FA; Jenkins, JJ; Lobe, TE; Lowe, EJ; Santana, VM	1
Ajmi, S; Arfaoui, D; Elloumi, H; Frikha, F; Mokni, M; Yacoubi, MT	1
Ain, KB; Dziba, JM	1
Blasick, TM; Brown, RE; Lun, M; Siegelmann-Danieli, N; Zhang, PL	1
Alimena, G; Breccia, M; Carmosino, I; Latagliata, R; Morano, SG; Russo, E	1
Brabant, G; Jakubcakova, V; Kant, S; Kremenevskaja, N; Rao, AS; Resch, J; von Wasielewski, R	1
Namba, H; Ohtsuru, A; Palona, I; Podtcheko, A; Rogounovitch, T; Saenko, V; Sedliarou, I; Starenki, D; Yamashita, S	1
Boogaerts, M; Cools, J; Folens, C; Lierman, E; Marynen, P; Mentens, N; Scheers, W; Stover, EH; Van Miegroet, H; Vandenberghe, P	1
Bucana, CD; Fidler, IJ; Kitadai, Y; Kuwai, T; Nakamura, T; Sasaki, T	1
Chen, A; Chen, YF; Kao, WY; Lee, WC; Sheu, LF; Young, ZH	1
Bergers, G; Hanahan, D; Pahler, J; Pietras, K	1
Fukumura, D; Jain, RK; Lahdenranta, J	1
Sherman, SI	1

Reviews

7 review(s) available for imatinib mesylate and Carcinoma, Anaplastic

Article	Year
Struma Ovarii With Malignant Transformation and Germline KIT Mutation: A Case Report With Review of the Literature. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists, 2016, Volume: 35, Issue:5 Topics: Antineoplastic Agents; Carcinoma; Carcinoma, Papillary; DNA Mutational Analysis; Female; Germ-Line Mutation; Humans; Imatinib Mesylate; Middle Aged; Ovarian Neoplasms; Prognosis; Proto-Oncogene Proteins c-kit; Struma Ovarii; Teratoma; Thyroid Cancer, Papillary; Thyroid Neoplasms	2016
Extra-abdominal subcutaneous metastasis of a gastrointestinal stromal tumor: report of a case and a review of the literature. Journal of cutaneous pathology, 2009, Volume: 36, Issue:5 Topics: Aged; Antineoplastic Agents; Benzamides; Biomarkers, Tumor; Bone Neoplasms; Carcinoma; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunohistochemistry; Indoles; Liver Neoplasms; Piperazines; Pyrimidines; Pyrroles; Soft Tissue Neoplasms; Subcutaneous Fat; Sunitinib	2009
Tyrosine kinase inhibitors and solid tumours: case report and review of the literature. Pharmacology, 2009, Volume: 84, Issue:1 Topics: Administration, Oral; Benzamides; Carcinoma; Dasatinib; Fatal Outcome; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Neoplasm Metastasis; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Thiazoles	2009
BCR-ABL-mediated upregulation of PRAME is responsible for knocking down TRAIL in CML patients. Oncogene, 2011, Jan-13, Volume: 30, Issue:2 Topics: Adenocarcinoma; Antigens, Neoplasm; Antineoplastic Agents; Benzamides; Breast Neoplasms; Carcinoma; Cell Line; Disease Progression; DNA-Binding Proteins; Enhancer of Zeste Homolog 2 Protein; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Neoplasms; Melanoma; Piperazines; Polycomb Repressive Complex 2; Promoter Regions, Genetic; Pyrimidines; RNA Interference; TNF-Related Apoptosis-Inducing Ligand; Transcription Factors; Tumor Cells, Cultured; Up-Regulation	2011
The role of targeted molecular inhibitors in the management of advanced nonmelanoma skin cancer. Seminars in cutaneous medicine and surgery, 2011, Volume: 30, Issue:1 Topics: Anilides; Antineoplastic Agents; Benzamides; Carcinoma; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Dermatofibrosarcoma; ErbB Receptors; Head and Neck Neoplasms; Humans; Imatinib Mesylate; Molecular Targeted Therapy; Neoplasms, Squamous Cell; Piperazines; Pyridines; Pyrimidines; Skin Neoplasms; Squamous Cell Carcinoma of Head and Neck	2011
[Gastrointestinal stromal tumors. Current data]. La Tunisie medicale, 2003, Volume: 81, Issue:12 Topics: Antineoplastic Agents; Benzamides; Carcinoma; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Piperazines; Prognosis; Proto-Oncogene Proteins c-kit; Pyrimidines; Stromal Cells	2003
Early clinical studies of novel therapies for thyroid cancers. Endocrinology and metabolism clinics of North America, 2008, Volume: 37, Issue:2 Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Axitinib; Benzamides; Benzenesulfonates; Carcinoma; Clinical Trials as Topic; Drug Delivery Systems; Gefitinib; Humans; Imatinib Mesylate; Imidazoles; Indazoles; Indoles; Niacinamide; Oligonucleotides; Phenylurea Compounds; Piperazines; Piperidines; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Quinazolines; Sorafenib; Thyroid Neoplasms	2008

Trials

1 trial(s) available for imatinib mesylate and Carcinoma, Anaplastic

Article	Year
A phase II study of imatinib in patients with advanced anaplastic thyroid cancer. Thyroid : official journal of the American Thyroid Association, 2010, Volume: 20, Issue:9 Topics: Aged; Antineoplastic Agents; Benzamides; Carcinoma; Disease-Free Survival; Female; Humans; Imatinib Mesylate; Male; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Thyroid Neoplasms	2010

Article

Year

A phase II study of imatinib in patients with advanced anaplastic thyroid cancer.

Thyroid : official journal of the American Thyroid Association, 2010, Volume: 20, Issue:9

Topics: Aged; Antineoplastic Agents; Benzamides; Carcinoma; Disease-Free Survival; Female; Humans; Imatinib Mesylate; Male; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Thyroid Neoplasms

2010

Other Studies

22 other study(ies) available for imatinib mesylate and Carcinoma, Anaplastic

Article	Year
Cystic Ileal Gastrointestinal Stromal Tumor Masquerading as Metastatic Adnexal Carcinoma. Journal of gastrointestinal cancer, 2020, Volume: 51, Issue:3 Topics: Abdominal Cavity; Aged; Carcinoma; Chemotherapy, Adjuvant; Cysts; Diagnosis, Differential; Female; Gastrointestinal Stromal Tumors; Humans; Ileal Neoplasms; Ileum; Imatinib Mesylate; Laparoscopy; Ovarian Neoplasms; Pelvis; Peritoneal Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography	2020
KRAS and KIT Gatekeeper Mutations Confer Polyclonal Primary Imatinib Resistance in GI Stromal Tumors: Relevance of Concomitant Phosphatidylinositol 3-Kinase/AKT Dysregulation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Aug-01, Volume: 33, Issue:22 Topics: Antineoplastic Agents; Arginine; Benzamides; Carcinoma; Drug Resistance, Neoplasm; Gastrointestinal Stromal Tumors; Glycine; Humans; Imatinib Mesylate; Isoleucine; Male; Middle Aged; Mutation; Phosphatidylinositol 3-Kinase; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-kit; Proto-Oncogene Proteins p21(ras); Pyrimidines; ras Proteins; Sequence Analysis, DNA; Signal Transduction; Stomach Neoplasms; Threonine; Time Factors; TOR Serine-Threonine Kinases	2015
Unexpected DOG-1 immunoreactivity in sarcomatous carcinoma of the liver: a diagnostic pitfall. Pathology, 2014, Volume: 46, Issue:6 Topics: Aged; Anoctamin-1; Antineoplastic Agents; Autopsy; Bile Duct Neoplasms; Carcinoma; Carcinoma, Hepatocellular; Chloride Channels; Diagnosis, Differential; Fatal Outcome; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver; Liver Neoplasms; Male; Neoplasm Proteins; Sarcoma; Tomography, X-Ray Computed; Ultrasonography	2014
The Tyrosine Kinase Inhibitor Imatinib Augments Extracellular Fluid Exchange and Reduces Average Collagen Fibril Diameter in Experimental Carcinoma. Molecular cancer therapeutics, 2016, Volume: 15, Issue:10 Topics: Animals; Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Collagen; Disease Models, Animal; Endothelial Cells; Extracellular Fluid; Female; Humans; Imatinib Mesylate; Immunohistochemistry; Mice; Pericytes; Protein Aggregates; Protein Kinase Inhibitors; Stromal Cells; Xenograft Model Antitumor Assays	2016
Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2017, 01-01, Volume: 28, Issue:1 Topics: Adult; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma; DNA Mutational Analysis; Gene Expression Profiling; High-Throughput Nucleotide Sequencing; Humans; Imatinib Mesylate; Immunohistochemistry; Male; Mutation; Paranasal Sinus Neoplasms; Proto-Oncogene Proteins c-kit	2017
Fatal heart failure after a 26-month combination of tyrosine kinase inhibitors in a papillary thyroid cancer. Thyroid : official journal of the American Thyroid Association, 2011, Volume: 21, Issue:4 Topics: Acute Coronary Syndrome; Benzamides; Benzenesulfonates; Carcinoma; Carcinoma, Papillary; Fatal Outcome; Humans; Imatinib Mesylate; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Radiography; Sorafenib; Thyroid Cancer, Papillary; Thyroid Neoplasms	2011
Imatinib enhances docetaxel-induced apoptosis through inhibition of nuclear factor-κB activation in anaplastic thyroid carcinoma cells. Thyroid : official journal of the American Thyroid Association, 2012, Volume: 22, Issue:7 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cell Survival; Docetaxel; Drug Synergism; Humans; Imatinib Mesylate; NF-kappa B; Piperazines; Pyrimidines; Taxoids; Thyroid Neoplasms	2012
Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium. Cancer, 2003, Aug-15, Volume: 98, Issue:4 Topics: Antineoplastic Agents; Benzamides; Carcinoma; Enzyme Inhibitors; Epithelium; Female; Humans; Imatinib Mesylate; Immunohistochemistry; Ovarian Neoplasms; Ovary; Piperazines; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-abl; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptor, Platelet-Derived Growth Factor beta	2003
Effect of imatinib mesylate (Gleevec) on anaplastic thyroid carcinoma cell lines. The Journal of clinical endocrinology and metabolism, 2003, Volume: 88, Issue:10 Topics: Antineoplastic Agents; Benzamides; Carcinoma; Humans; Imatinib Mesylate; Piperazines; Pyrimidines; Thyroid Neoplasms; Tumor Cells, Cultured	2003
Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model. Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Dec-15, Volume: 9, Issue:17 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Becaplermin; Benzamides; Blotting, Western; Carcinoma; Cell Division; Cell Line, Tumor; Humans; Imatinib Mesylate; Immunohistochemistry; In Situ Nick-End Labeling; Ligands; Mice; Mice, Nude; Microscopy, Fluorescence; Neoplasm Metastasis; Pancreatic Neoplasms; Phosphorylation; Piperazines; Platelet Endothelial Cell Adhesion Molecule-1; Platelet-Derived Growth Factor; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-sis; Pyrimidines; Receptor, Platelet-Derived Growth Factor beta; Receptors, Platelet-Derived Growth Factor; Time Factors	2003
Inhibition of cell survival and invasive potential of colorectal carcinoma cells by the tyrosine kinase inhibitor STI571. Cancer biology & therapy, 2004, Volume: 3, Issue:4 Topics: Apoptosis; Benzamides; Carcinoma; Cell Communication; Cell Survival; Colorectal Neoplasms; Humans; Imatinib Mesylate; Male; Middle Aged; Neoplasm Invasiveness; Piperazines; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-bcl-2; Pyrimidines; Tumor Cells, Cultured	2004
Anemia and a large abdominal tumor in an adolescent. Pediatric blood & cancer, 2004, Volume: 42, Issue:2 Topics: Abdominal Muscles; Adolescent; Anemia; Antineoplastic Agents; Benzamides; Carcinoma; Combined Modality Therapy; Humans; Imatinib Mesylate; Magnetic Resonance Imaging; Male; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Stomach Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed	2004
Imatinib mesylate (gleevec; STI571) monotherapy is ineffective in suppressing human anaplastic thyroid carcinoma cell growth in vitro. The Journal of clinical endocrinology and metabolism, 2004, Volume: 89, Issue:5 Topics: Antineoplastic Agents; Benzamides; Carcinoma; Cell Cycle; Cell Division; Cell Line, Tumor; Dose-Response Relationship, Drug; Gene Expression; Genes, abl; Humans; Imatinib Mesylate; Oncogene Proteins; Phosphorylation; Piperazines; Proto-Oncogene Proteins c-abl; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptor, Platelet-Derived Growth Factor beta; Thyroid Neoplasms; Tyrosine	2004
Pamidronate resistance and associated low ras levels in breast cancer cells: a role for combinatorial therapy. Annals of clinical and laboratory science, 2004,Summer, Volume: 34, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Boronic Acids; Bortezomib; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Cell Proliferation; Diphosphonates; Drug Combinations; Drug Resistance, Neoplasm; Female; Humans; Imatinib Mesylate; Pamidronate; Piperazines; Pyrazines; Pyrimidines; ras Proteins; Sirolimus	2004
Early and tardive skin adverse events in chronic myeloid leukaemia patients treated with imatinib. European journal of haematology, 2005, Volume: 74, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Carcinoma; Drug Eruptions; Edema; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Nausea; Piperazines; Pyrimidines; Skin Neoplasms; Vomiting; Weight Gain	2005
Wnt/beta-catenin signaling mediates antineoplastic effects of imatinib mesylate (gleevec) in anaplastic thyroid cancer. The Journal of clinical endocrinology and metabolism, 2006, Volume: 91, Issue:1 Topics: Antineoplastic Agents; Apoptosis; Benzamides; beta Catenin; Blotting, Western; Carcinoma; Caspase 3; Caspase 7; Caspases; Cell Proliferation; Collagen; Drug Combinations; Fluorescent Antibody Technique; Genes, Reporter; Humans; Imatinib Mesylate; Immunoprecipitation; Laminin; Luciferases; Microscopy, Confocal; Oligonucleotide Array Sequence Analysis; Piperazines; Proteoglycans; Pyrimidines; Signal Transduction; Tetrazolium Salts; Thiazoles; Thymidine; Thyroid Neoplasms; Transfection; Tumor Cells, Cultured	2006
Inhibition of ABL tyrosine kinase potentiates radiation-induced terminal growth arrest in anaplastic thyroid cancer cells. Radiation research, 2006, Volume: 165, Issue:1 Topics: Apoptosis; Benzamides; Carcinoma; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Radiation Dosage; Radiation Tolerance; Thyroid Neoplasms	2006
Sorafenib is a potent inhibitor of FIP1L1-PDGFRalpha and the imatinib-resistant FIP1L1-PDGFRalpha T674I mutant. Blood, 2006, Aug-15, Volume: 108, Issue:4 Topics: Benzamides; Benzenesulfonates; Carcinoma; Cell Proliferation; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; K562 Cells; Kidney Neoplasms; mRNA Cleavage and Polyadenylation Factors; Mutation; Niacinamide; Oncogene Proteins, Fusion; Phenylurea Compounds; Piperazines; Point Mutation; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Sorafenib	2006
Targeting the expression of platelet-derived growth factor receptor by reactive stroma inhibits growth and metastasis of human colon carcinoma. The American journal of pathology, 2006, Volume: 169, Issue:6 Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Camptothecin; Carcinoma; Cecum; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Drug Synergism; Humans; Imatinib Mesylate; Irinotecan; Liver; Male; Mice; Mice, Nude; Pericytes; Piperazines; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Stromal Cells; Transplantation, Heterologous	2006
STI571 sensitizes nasopharyngeal carcinoma cells to cisplatin: sustained activation of ERK with improved growth inhibition. International journal of oncology, 2007, Volume: 30, Issue:2 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Carcinoma; Cell Death; Cell Proliferation; Cisplatin; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Humans; Imatinib Mesylate; Inhibitory Concentration 50; Male; Mice; Nasopharyngeal Neoplasms; Neoplasm Transplantation; Phosphorylation; Piperazines; Pyrimidines	2007
Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting. PLoS medicine, 2008, Jan-29, Volume: 5, Issue:1 Topics: Animals; Antineoplastic Agents; Benzamides; Carcinoma; Epithelial Cells; Estradiol; Female; Fibroblast Growth Factor 2; Fibroblast Growth Factor 7; Fibroblasts; Human papillomavirus 16; Humans; Imatinib Mesylate; Mice; Mice, Inbred Strains; Mice, Transgenic; Neoplasm Proteins; Neovascularization, Pathologic; Paracrine Communication; Pericytes; Piperazines; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Stromal Cells; Uterine Cervical Neoplasms	2008
Targeting PDGF signaling in carcinoma-associated fibroblasts controls cervical cancer in mouse model. PLoS medicine, 2008, Jan-29, Volume: 5, Issue:1 Topics: Animals; Antineoplastic Agents; Benzamides; Carcinoma; Drug Delivery Systems; Drug Screening Assays, Antitumor; Female; Fibroblasts; Imatinib Mesylate; Mice; Neoplasm Proteins; Neovascularization, Pathologic; Paracrine Communication; Pericytes; Piperazines; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Uterine Cervical Neoplasms	2008